title: Microcell-mediated chromosome transfer provides evidence that polysomy promotes structural instability in tumor cell chromosomes through asynchronous replication and breakage within late-replicating regions.
abstract: It was reported earlier that normal chromosome 3 (chr3) transfer into tumor cells of different origin may suppress their ability to grow in SCID mice. Tumorigenicity may be restored by the loss of certain 3p regions. We transferred a normal cell-derived chr3 into cells of a human renal cell carcinoma line and followed the chromosomal changes during in vivo and in vitro growth. In cells cultivated for 6 weeks or more and in the tumors grown in SCID mice, supernumerary chrs3 were always rearranged, accompanied by 3p losses. Unexpectedly, we found that the rearrangements affected not only the transferred exogenous chr3, but also the endogenous chrs3. Other chromosomes that were polysomic in the recipient cells were affected as well, suggesting that polysomy may be associated with structural chromosome instability. The dominant chromosomal aberrations were unbalanced translocations with preferentially pericentromeric breakpoints. The breakpoint distribution on chr3 preferentially affected the pericentromeric 3p11 (8 breaks) and 3p12-13 (5 breaks) regions. The regions 3p14 and 3q26-27 occasionally were involved as well (one break in each case). These four regions were the latest replicating, as shown by BrdU incorporation-based replication banding. Using fluorescence in situ hybridization-based replication timing, we detected asynchronous and incomplete centromere replication in cells with 3 or 4 copies of chr3, but not in cells with 2. We concluded that in tumor cells, asynchronous and incomplete replication of polysomic chromosomal parts is associated with aberrations that have breakpoints within the late-replicating regions. This may explain the increased structural chromosome instability and preferential pericentromeric localization of breakpoints in hyperploid tumors.
authors.affiliation: Microbiology and Tumor Biology Center, Karolinska Institute, Stockholm, Sweden. Maria.Kost-Alimova@mtc.ki.se
authors.forename: Maria
authors.initials: M
authors.lastname: Kost-Alimova
authors.forename: Ludmila
authors.initials: L
authors.lastname: Fedorova
authors.forename: Ying
authors.initials: Y
authors.lastname: Yang
authors.forename: George
authors.initials: G
authors.lastname: Klein
authors.forename: Stefan
authors.initials: S
authors.lastname: Imreh
mesh_terms: D000782:Aneuploidy; D000818:Animals; D002292:Carcinoma, Renal Cell / Q000235:genetics* / Q000473:pathology; D002453:Cell Cycle / Q000235:genetics; D045744:Cell Line, Tumor; D002503:Centromere / Q000235:genetics; D002869:Chromosome Aberrations; D019457:Chromosome Breakage / Q000235:genetics*; D002893:Chromosomes, Human, Pair 3 / Q000235:genetics; D042522:DNA Replication Timing / Q000235:genetics*; D004273:DNA, Neoplasm / Q000235:genetics; D005354:Fibrosarcoma / Q000235:genetics* / Q000473:pathology; D006801:Humans; D006822:Hybrid Cells / Q000737:chemistry / Q000378:metabolism; D007680:Kidney Neoplasms / Q000235:genetics* / Q000473:pathology; D051379:Mice; D009368:Neoplasm Transplantation / Q000379:methods; D016196:S Phase / Q000235:genetics; D014178:Translocation, Genetic / Q000235:genetics
chemical_list: D004273:DNA, Neoplasm